2. Signaling Pathways
  3. Metabolic Enzyme/Protease
  4. Drug Metabolite
  5. Drug Metabolite Inhibitor

Drug Metabolite Inhibitor

Drug Metabolite Inhibitors (4):

Cat. No. Product Name Effect Purity
  • HY-W003467
    Rabeprazole Sulfide
    		Inhibitor 99.26%
    Rabeprazole Sulfide is a sulfide metabolite of Rabeprazole (HY-B0656). Rabeprazole Sulfide inhibits Helicobacter pylori motility. Rabeprazole Sulfide can be used for the research of Helicobacter pylori infection.
  • HY-119694
    Rotenolone
    		Inhibitor
    Rotenolone is a metabolite of Rotenone (HY-B1756), inhibitor of Mitochondrial complex I, and antiproliferative agent, with an IC50 of 137 nM against bovine complex I. Rotenolone undergoes biotransformation via multiple cytochrome P450 isoenzymes in rainbow trout liver microsomes. Rotenolone exhibits anticancer activity against ovarian cancer, breast cancer, prostate cancer, non-small cell lung cancer, and colon cancer. Rotenolone can be used in studies related to ovarian cancer, breast cancer, prostate cancer, non-small cell lung cancer, and colon cancer.
  • HY-127159
    Laurencin
    		Inhibitor
    Laurencin is a cyclic ether, which can be isolated red alga L. glandulifera. Laurencin prolongs the pentobarbitone-induced sleep time through inhibition of pentobarbitone metabolism.
  • HY-W721612
    Bromebric acid
    		Inhibitor
    Bromobric acid is a derivative of bromoacrylic acid with cytostatic and antineoplastic activity that can form ionic complexes with glucosamine to achieve controlled-release oral administration